Commerce Bank Invests $36.90 Million in Danaher Corporation $DHR

Commerce Bank acquired a new stake in Danaher Corporation (NYSE:DHR) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 193,732 shares of the conglomerate’s stock, valued at approximately $36,902,000.

Other large investors have also recently added to or reduced their stakes in the company. Sivia Capital Partners LLC grew its holdings in Danaher by 6.3% in the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock valued at $397,000 after buying an additional 119 shares during the period. First Trust Advisors LP boosted its position in shares of Danaher by 34.5% in the second quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock worth $10,947,000 after acquiring an additional 14,217 shares during the last quarter. Main Street Financial Solutions LLC boosted its position in shares of Danaher by 40.2% in the second quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock worth $610,000 after acquiring an additional 886 shares during the last quarter. Ieq Capital LLC grew its holdings in Danaher by 64.2% in the second quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock valued at $14,957,000 after purchasing an additional 29,592 shares during the period. Finally, HUB Investment Partners LLC grew its holdings in Danaher by 30.7% in the second quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock valued at $273,000 after purchasing an additional 325 shares during the period. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Price Performance

DHR opened at $219.42 on Friday. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company has a 50 day moving average of $195.80 and a two-hundred day moving average of $192.61. The company has a market cap of $154.25 billion, a P/E ratio of 38.97, a P/E/G ratio of 2.72 and a beta of 0.78.

Danaher (NYSE:DHR) last issued its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The business had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same quarter last year, the firm posted $0.77 EPS. On average, analysts expect that Danaher Corporation will post 8.53 earnings per share for the current year.

Analysts Set New Price Targets

A number of research firms have weighed in on DHR. Citigroup began coverage on shares of Danaher in a research note on Tuesday, May 26th. They set a “buy” rating and a $230.00 price target on the stock. TD Cowen cut their target price on Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. DZ Bank started coverage on Danaher in a report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 target price on the stock. Stifel Nicolaus lowered their price target on Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Finally, Wells Fargo & Company dropped their price target on Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $228.91.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.